Request a document copy: A randomized, multicentric phase II study of preoperative nivolumab plus relatlimab or nivolumab in patients with resectable non-small cell lung cancer (NEOpredict-Lung)

all files (of this document) in restricted access
the file(s) you requested
Cancel